168 related articles for article (PubMed ID: 22249254)
1. Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155.
Lee DW; Futami M; Carroll M; Feng Y; Wang Z; Fernandez M; Whichard Z; Chen Y; Kornblau S; Shpall EJ; Bueso-Ramos CE; Corey SJ
Oncogene; 2012 Sep; 31(37):4085-94. PubMed ID: 22249254
[TBL] [Abstract][Full Text] [Related]
2. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
[TBL] [Abstract][Full Text] [Related]
3. [The mechanism for SHIP gene to induce the apoptosis of human leukemia cell line K562.].
Yang L; Luo JM; Liu XJ; Wen SP; Du XY; Yao L; Yang JC
Sheng Li Xue Bao; 2009 Apr; 61(2):146-54. PubMed ID: 19377826
[TBL] [Abstract][Full Text] [Related]
4. The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis.
Lakhanpal GK; Vecchiarelli-Federico LM; Li YJ; Cui JW; Bailey ML; Spaner DE; Dumont DJ; Barber DL; Ben-David Y
Blood; 2010 Jul; 116(3):428-36. PubMed ID: 20445019
[TBL] [Abstract][Full Text] [Related]
5. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
6. Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases.
Miletic AV; Anzelon-Mills AN; Mills DM; Omori SA; Pedersen IM; Shin DM; Ravetch JV; Bolland S; Morse HC; Rickert RC
J Exp Med; 2010 Oct; 207(11):2407-20. PubMed ID: 20956547
[TBL] [Abstract][Full Text] [Related]
7. Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients.
Nyåkern M; Tazzari PL; Finelli C; Bosi C; Follo MY; Grafone T; Piccaluga PP; Martinelli G; Cocco L; Martelli AM
Leukemia; 2006 Feb; 20(2):230-8. PubMed ID: 16341040
[TBL] [Abstract][Full Text] [Related]
8. TET1-mediated microRNA-188-5p promoter hydroxymethylation regulates PTEN/PI3K/AKT signaling pathway in acute myeloid leukemia cells.
Lu N; Wang X; Wang W; Tang M; Chen J; You H; Wang D
Arch Biochem Biophys; 2023 Mar; 736():109523. PubMed ID: 36682704
[TBL] [Abstract][Full Text] [Related]
9. [Inhibitory effect of lentiviral vector-mediated SHIP gene transfection on proliferation of leukemia K562 cells and PI3K/Akt pathway regulation].
Yang L; Luo JM; Liu XJ; Wen SP; Du XY; Yao L
Ai Zheng; 2009 Apr; 28(4):366-72. PubMed ID: 19622295
[TBL] [Abstract][Full Text] [Related]
10. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of SHIP gene in acute leukemia.
Luo JM; Liu ZL; Hao HL; Wang FX; Dong ZR; Ohno R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):420-6. PubMed ID: 15363123
[TBL] [Abstract][Full Text] [Related]
12. Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and function.
Pilon-Thomas S; Nelson N; Vohra N; Jerald M; Pendleton L; Szekeres K; Ghansah T
PLoS One; 2011; 6(11):e27729. PubMed ID: 22132131
[TBL] [Abstract][Full Text] [Related]
13. SHIP1 is targeted by miR-155 in acute myeloid leukemia.
Xue H; Hua LM; Guo M; Luo JM
Oncol Rep; 2014 Nov; 32(5):2253-9. PubMed ID: 25175984
[TBL] [Abstract][Full Text] [Related]
14. Effects of MicroRNA-19b on the Proliferation, Apoptosis, and Migration of Wilms' Tumor Cells Via the PTEN/PI3K/AKT Signaling Pathway.
Liu GL; Yang HJ; Liu B; Liu T
J Cell Biochem; 2017 Oct; 118(10):3424-3434. PubMed ID: 28322459
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of microRNA‑21 expression inhibits proliferation, and induces G1 arrest and apoptosis via the PTEN/AKT pathway in SKM‑1 cells.
Li G; Song Y; Li G; Ren J; Xie J; Zhang Y; Gao F; Mu J; Dai J
Mol Med Rep; 2018 Sep; 18(3):2771-2779. PubMed ID: 30015844
[TBL] [Abstract][Full Text] [Related]
17. Anemia, thrombocytopenia, leukocytosis, extramedullary hematopoiesis, and impaired progenitor function in Pten+/-SHIP-/- mice: a novel model of myelodysplasia.
Moody JL; Xu L; Helgason CD; Jirik FR
Blood; 2004 Jun; 103(12):4503-10. PubMed ID: 15001465
[TBL] [Abstract][Full Text] [Related]
18. Differential association of phosphatidylinositol 3-kinase, SHIP-1, and PTEN with forming phagosomes.
Kamen LA; Levinsohn J; Swanson JA
Mol Biol Cell; 2007 Jul; 18(7):2463-72. PubMed ID: 17442886
[TBL] [Abstract][Full Text] [Related]
19. Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia.
Luo JM; Yoshida H; Komura S; Ohishi N; Pan L; Shigeno K; Hanamura I; Miura K; Iida S; Ueda R; Naoe T; Akao Y; Ohno R; Ohnishi K
Leukemia; 2003 Jan; 17(1):1-8. PubMed ID: 12529653
[TBL] [Abstract][Full Text] [Related]
20. [The correlation study of PTEN gene expression and Akt phosphorylation in myelodysplastic syndrome].
Chen BG; Zhu M; Luo WD; Yan WH; Zhou MY; Li BL; Tao DD
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):470-3. PubMed ID: 18072631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]